Thomas K Equels

CIK 1450324 · CEO & President · last filed 2026-03-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$25.9K

Companies

2

Total Filings

106

Lifetime Open-Market Net

$1.08M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
AIM	CEO & President	63,922	$0.41	$25.9K	$401.1K	51	2026-03-16
AIM ImmunoTech Inc. (HEB) Delisted	Exec. Vice Chairman/CEO/Pres.	63,041	—	—	$678.2K	55	2019-06-27

Recent Filings · Page 5 of 11

106 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2020-12-17	AIM	Buy (P)	+14,535	$25.0K	EDGAR
2020-11-13	AIM	Grant (A)	—	$0	EDGAR
2020-09-03	AIM	Buy (P)	+12,316	$25.0K	EDGAR
2020-08-21	AIM	Buy (P)	+10,730	$25.0K	EDGAR
2020-08-14	AIM	Grant (A)	—	$0	EDGAR
2020-01-02	AIM	Grant (A)	+14,741	$7.8K	EDGAR
2019-12-16	AIM	Grant (A)	+17,960	$7.8K	EDGAR
2019-12-02	AIM	Grant (A)	+19,531	$7.8K	EDGAR
2019-11-18	AIM	Grant (A)	+16,622	$7.8K	EDGAR
2019-10-31	AIM	Grant (A)	+15,625	$7.8K	EDGAR

Showing 41–50 of 106

Prev Page 5 of 11 Next

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.